BYE-LAWS FOR THE DEGREE OF MASTER OF PHARMACY - M.PHARM. - UNDER THE AUSPICES OF THE FACULTY OF MEDICINE AND SURGERY

DEGREE OF MASTER OF PHARMACY - M.PHARM -

UNDER THE AUSPICES OF THE FACULTY

OF MEDICINE AND SURGERY

SUBSIDIARY LEGISLATION 327.419

BYE-LAWS FOR THE DEGREE OF MASTER OF

PHARMACY - M.PHARM. - UNDER THE AUSPICES

OF THE FACULTY OF MEDICINE AND SURGERY

24th January, 2012

LEGAL NOTICE 27 of 2012, as amended by Legal Notices 290 of 2012,

211 of 2013 and 302 of 2016.

(1) The title of these bye-laws is the Bye-Laws for the

Degree of Master of Pharmacy - M.Pharm. - under the auspices of

the Faculty of Medicine and Surgery.

(2)

In these bye-laws, unless the context otherwise requires -

"the Board" means the Board of the Faculty of Medicine and

Surgery;

"the course" means the programme of study leading to the degree

of Master of Pharmacy - M.Pharm.;

"t h e D eg r ee " m ea n s t h e d e g r e e o f M a s t e r o f P h a r m a c y -

M.Pharm.; and

"the Principal Regulations" means the General Regulations for

University Postgraduate Awards.

These bye-laws shall be

applicable

for

courses

commencing in October 2018 or later.

(1) The course shall be open to applicants in possession of

the degree of Bachelor of Science (Honours) in Pharmaceutical

Science comprising 240 ECTS credits, obtained with at least

Second Class Honours.

(2) Applicants in possession of the degree of Bachelor of

Science (Honours) (Pharmaceutical Science) obtained with Third

Class Honours shall be eligible to apply if they submit a portfolio

covering three years’ practice in an area related to pharmacy.

(3) Applicants in possession of the Bachelor of Pharmacy

(Honours) degree obtained with at least Second Class Honours after

successfully completing a five-year programme of study shall be

eligible to apply for a 30-credit programme of study.

(4)

Applicants in possession of the Bachelor of Pharmacy

(Honours) degree obtained with Third Class Honours or Pass after

successfully completing a five-year programme of study shall be

eligible to apply for a 30-credit programme of study if they submit

a portfolio covering at least three year’s practice in an area related to

pharmacy.

DEGREE OF MASTER OF PHARMACY - M.PHARM -

UNDER THE AUSPICES OF THE FACULTY

OF MEDICINE AND SURGERY

(1) The course shall extend over three semesters of full-

time study.

(2) The programme of study for graduates of the 5-year course

leading to the degree of Bachelor of Pharmacy (Honours) that

commenced between 1995 and 2006 shall extend over one semester

of full-time study or the equivalent in part-time study.

(1) The programme of study shall comprise study-units to

which a total of 90 credits are assigned, of which 60 credits are

assigned to taught and practical study-units and 30 credits are

assigned to the dissertation study-unit.

(2) The programme of study shall be published after approval

by Senate, normally not less than eight months prior to the

commencement of the course and shall include

(a) theoretical and practical training in the following

subjects

Pharmacy Practice

Clinical Pharmacy

Community Health Care

Legislation and Professional Ethics;

(b) at least six months of in-service training in a pharmacy

open to the public or in a hospital under the

supervision of the pharmaceutical department of that

hospital; and

(c) a dissertation study-unit.

(3) The programme of study referred to in bye-law 3(3) and (4)

shall comprise study-units to which a total of 30 credits are

assigned and shall consist of the following study-units

Patient Care Management

Pharmaceutical Regulatory Affairs

Research Paper.

The assessment of the taught study-units shall be held by

the end of the semester in which the teaching of the study-units is

held.

(1) Students shall be required to submit an individual

dissertation of approximately 25,000 words. The title of the

dissertation and a detailed research proposal shall be submitted at

the time of application.

(2) Each student shall be assigned a supervisor who shall

provide guidance and advice on a continuous basis during the

period of study.

(1) Students shall be required to have regular contact with

their supervisor.

(2) Supervisors shall submit to the Board progress reports for

each student under their supervision at the end of each semester of

DEGREE OF MASTER OF PHARMACY - M.PHARM -

UNDER THE AUSPICES OF THE FACULTY

OF MEDICINE AND SURGERY

study. Such reports may include a recommendation to either (a)

extend the period of study in order to enable the student to

complete the dissertation; or (b) terminate studies prematurely if

the supervisor deems this to be proper in the circumstances,

provided that

(i)

the extension of the study period referred to in (a) shall

be in accordance with the provisions of the Principal

Regulations; and

(ii) the Board may not terminate studies prematurely

according to (b) until it has first given the student a

chance to be heard.

(1) The Final Weighted Average Mark for the purpose of

the classification of the Degree shall be based on the results

obtained in all the components of the programme of study, all

credits being weighted equally.

(2) The Final Weighted Average Mark for the purpose of the

classification of the Degree for students who follow the 30-credit

programme of study shall take into account the results obtained in

the study-units of the fifth year of the Bachelor of Pharmacy

(Honours) course as well as the results obtained in the 30-credit

programme of study.